It’s always the little things in life that give us the most meaning.

Morning coffee, bright flowers, sweet treats, and furry friends.
Any day that has those four things is by all measures - a good day.
And the science on that is clear - little hits of dopamine sprinkled throughout the day do more for our mood and overall well-being than singular big hits. Scientifically, it’s the small things that add up to have the greatest impact.
That same sentiment is widespread in healthcare technology. Every line of code, every small detail in a program - they add up to pretty significant things. Like how many clicks a physician will make before getting to the data they need, or how effectively a lab will process blood work orders.
It’s a mindset my J2 colleagues all share - the keen awareness that “little” things like terminology or lines of code add up to the biggest impact for patients and clinicians. Healthcare is built on thousands of smart, careful decisions that make systems more usable, more connected, and more human.
And over time, those small improvements add up to something meaningful.

Thank you for choosing us as your partner - we look forward to every project still to come!

Rachel Warnock 💖
Director of Marketing

2026 ASTP Annual Meeting



The recent ASTP conference was a welcome blend of pink hearts and friendly faces - many of whom we hadn’t seen since the Civitas Annual Conference back in September. Reunions were joyous, met with huge smiles and warm hugs. It was just what the doctor ordered to break up the hardest part of winter.

Highlights of the event include the Civitas networking coffee hour (Civitas knows how to gather the best people, no matter where we are!) and the closing panel session on The Tech (r)Evolution of Healthcare Research and Clinical Trials. This closing panel was a Who’s Who of advancing the quality of clinical trials, from Ashita Batavia, the Global Head of Study Innovation at J&J Innovative Medicine, to James McDermott, the Head of HL7’s Vulcan FHIR accelerator, which is dedicated to advancing the research to care continuum through FHIR. The panel was moderated by Stephen Konya, Chief of Innovation and Strategic Partnerships at the ASTP, one of our gracious hosts for the week.

••••• J2 Industry News •••••